C Li, H Sun, W Wei, Q Liu, Y Wang, Y Zhang, F Lian… - Cellular Oncology, 2020 - Springer
Background Mitoxantrone (MTX) is a synthetic compound used as a second line
chemotherapeutic drug for prostate cancer. It has been reported to trigger immunogenic cell …